Free Trial

Caligan Partners Lp Top Holdings and 13F Report (2023)

About Caligan Partners Lp

Investment Activity

  • Caligan Partners Lp has $378.31 million in total holdings as of December 31, 2022.
  • Caligan Partners Lp owns shares of 12 different stocks, but just 5 companies or ETFs make up 80% of its holdings.
  • Approximately 17.68% of the portfolio was purchased this quarter.
  • About 6.82% of the portfolio was sold this quarter.
  • This quarter, Caligan Partners Lp has purchased 11 new stocks and bought additional shares in 5 stocks.
  • Caligan Partners Lp sold shares of 1 stock and completely divested from 3 stocks this quarter.

Largest Holdings

Liquidia
$152,823,939
Alimera Sciences
$65,657,101
Anika Therapeutics
$36,474,222
Evolus
$26,444,334
Exelixis
$26,120,323

Largest New Holdings this Quarter

Enanta Pharmaceuticals
$14,981,902 Holding
OUTLOOK THERAPEUTICS INC
$5,970,000 Holding
BioCryst Pharmaceuticals
$3,853,190 Holding
I-Mab
$1,407,161 Holding

Largest Purchases this Quarter

Verona Pharma
1,113,383 shares (about $17.91M)
Enanta Pharmaceuticals
858,070 shares (about $14.98M)
Anika Therapeutics
354,633 shares (about $9.01M)
Evolus
571,025 shares (about $7.99M)
OUTLOOK THERAPEUTICS INC
500,000 shares (about $5.97M)

Largest Sales this Quarter

Y-mAbs Therapeutics
461,149 shares (about $7.50M)

Sector Allocation Over Time

Map of 500 Largest Holdings ofCaligan Partners Lp

 
 
Selling
 
 
Neutral
 
 
Buying
Issuer NameHoldings ValueApproximate Purchase/SaleChange in SharesShares Held% of PortfolioSector
Liquidia Co. stock logo
LQDA
Liquidia
$152,823,9390.0%10,360,94540.4%Medical
Alimera Sciences, Inc. stock logo
ALIM
Alimera Sciences
$65,657,1010.0%16,835,15417.4%Medical
Anika Therapeutics, Inc. stock logo
ANIK
Anika Therapeutics
$36,474,222$9,007,678 32.8%1,435,9939.6%Medical
Evolus, Inc. stock logo
EOLS
Evolus
$26,444,334$7,994,350 43.3%1,888,8817.0%Medical
Exelixis, Inc. stock logo
EXEL
Exelixis
$26,120,323$4,508,700 20.9%1,100,7306.9%Medical
Verona Pharma plc stock logo
VRNA
Verona Pharma
$20,859,832$17,914,332 608.2%1,296,4475.5%Medical
Enanta Pharmaceuticals, Inc. stock logo
ENTA
Enanta Pharmaceuticals
$14,981,902$14,981,902 New Holding858,0704.0%Medical
Agios Pharmaceuticals, Inc. stock logo
AGIO
Agios Pharmaceuticals
$14,172,950$1,253,753 9.7%484,7113.7%Medical
Y-mAbs Therapeutics, Inc. stock logo
YMAB
Y-mAbs Therapeutics
$9,549,108$7,498,283 -44.0%587,2762.5%Medical
OUTLOOK THERAPEUTICS INC
$5,970,000$5,970,000 New Holding500,0001.6%COM
BioCryst Pharmaceuticals, Inc. stock logo
BCRX
BioCryst Pharmaceuticals
$3,853,190$3,853,190 New Holding758,5021.0%Medical
I-Mab stock logo
IMAB
I-Mab
$1,407,161$1,407,161 New Holding756,5380.4%Medical
Standard BioTools Inc. stock logo
LAB
Standard BioTools
$0$15,563,733 -100.0%00.0%Medical
ADMA Biologics, Inc. stock logo
ADMA
ADMA Biologics
$0$2,138,353 -100.0%00.0%Medical
Societal CDMO, Inc. stock logo
SCTL
Societal CDMO
$0$592,264 -100.0%00.0%Medical

Showing largest 100 holdings. View all holdings.

More Institutional Buying and Selling Information

SEC Filings and Trading Data: